Search research articles
Contact Us
Filters
Showing results (1311-1320 of 1,388) with videos related to
Page
of 139
Sort By:
Nature Medicine
|
January 15, 2020
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration
Alexander Drilon, Jeffrey W Clark, Jared Weiss, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 20, 2024
Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer
Jonathan D Spicer, Tina Cascone, Murry W Wynes, et al.
The Lancet. Neurology
|
July 21, 2023
Differential diagnosis of suspected multiple sclerosis: an updated consensus approach
Andrew J Solomon, Georgina Arrambide, Wallace J Brownlee, et al.
JAMA Neurology
|
November 28, 2022
Autoimmune Encephalitis Misdiagnosis in Adults
Eoin P Flanagan, Michael D Geschwind, A Sebastian Lopez-Chiriboga, et al.
Nature Medicine
|
February 4, 2026
Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial
Benjamin Besse, Jessica J Lin, Lyudmila Bazhenova, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 10, 2017
Anti-Citrullinated Protein Antibodies Are Associated With Neutrophil Extracellular Traps in the Sputum in Relatives of Rheumatoid Arthritis Patients
M Kristen Demoruelle, Kylie K Harrall, Linh Ho, et al.
Respiratory Medicine
|
April 17, 2012
Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease
Aryeh Fischer, Joshua J Solomon, Roland M du Bois, et al.
Nature Reviews. Neurology
|
November 12, 2016
The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative
Pascal Sati, Jiwon Oh, R Todd Constable, et al.
Clinical Lung Cancer
|
September 23, 2022
Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic Considerations
Myung-Ju Ahn, Marvin Jonne L Mendoza, Nick Pavlakis, et al.
The New England Journal of Medicine
|
September 30, 2014
Crizotinib in ROS1-rearranged non-small-cell lung cancer
Alice T Shaw, Sai-Hong I Ou, Yung-Jue Bang, et al.
Page
of 139
Search research articles
Search
Showing results (1311-1320 of 1,388) with videos related to
Sort By:
Page
of 139
Nature Medicine
|
January 15, 2020
Antitumor activity of crizotinib in lung cancers harboring a MET exon 14 alteration
Alexander Drilon, Jeffrey W Clark, Jared Weiss, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
June 20, 2024
Neoadjuvant and Adjuvant Treatments for Early Stage Resectable NSCLC: Consensus Recommendations From the International Association for the Study of Lung Cancer
Jonathan D Spicer, Tina Cascone, Murry W Wynes, et al.
The Lancet. Neurology
|
July 21, 2023
Differential diagnosis of suspected multiple sclerosis: an updated consensus approach
Andrew J Solomon, Georgina Arrambide, Wallace J Brownlee, et al.
JAMA Neurology
|
November 28, 2022
Autoimmune Encephalitis Misdiagnosis in Adults
Eoin P Flanagan, Michael D Geschwind, A Sebastian Lopez-Chiriboga, et al.
Nature Medicine
|
February 4, 2026
Repotrectinib in NTRK fusion-positive advanced solid tumors: a phase 1/2 trial
Benjamin Besse, Jessica J Lin, Lyudmila Bazhenova, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
February 10, 2017
Anti-Citrullinated Protein Antibodies Are Associated With Neutrophil Extracellular Traps in the Sputum in Relatives of Rheumatoid Arthritis Patients
M Kristen Demoruelle, Kylie K Harrall, Linh Ho, et al.
Respiratory Medicine
|
April 17, 2012
Lung disease with anti-CCP antibodies but not rheumatoid arthritis or connective tissue disease
Aryeh Fischer, Joshua J Solomon, Roland M du Bois, et al.
Nature Reviews. Neurology
|
November 12, 2016
The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: a consensus statement from the North American Imaging in Multiple Sclerosis Cooperative
Pascal Sati, Jiwon Oh, R Todd Constable, et al.
Clinical Lung Cancer
|
September 23, 2022
Asian Thoracic Oncology Research Group (ATORG) Expert Consensus Statement on MET Alterations in NSCLC: Diagnostic and Therapeutic Considerations
Myung-Ju Ahn, Marvin Jonne L Mendoza, Nick Pavlakis, et al.
The New England Journal of Medicine
|
September 30, 2014
Crizotinib in ROS1-rearranged non-small-cell lung cancer
Alice T Shaw, Sai-Hong I Ou, Yung-Jue Bang, et al.
Page
of 139